Does Dr. SAILESH ARULKUMAR have financial conflicts of interest?

Dr. SAILESH ARULKUMAR (MBBS) has received a total of $158,278 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $158,278 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SAILESH ARULKUMAR?

According to CMS Open Payments data, Dr. SAILESH ARULKUMAR received funding from NALU MEDICAL ($155,035), RELIEVANT MEDSYSTEMS ($1,055), and BOSTON SCIENTIFIC CORPORATION ($534).

Does Dr. SAILESH ARULKUMAR receive research grants or speaking fees?

Dr. SAILESH ARULKUMAR has received $158,278 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SAILESH ARULKUMAR

MBBSReal-Time Hydrated

Specialty: Anesthesiology, Pain Medicine

Practice Location: OKLAHOMA CITY, OK 73106

NPI Number: 1174889778

LIFETIME INDUSTRY VALUE

$158,278

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ARULKUMAR is a verified Anesthesiology, Pain Medicine practitioner based in OKLAHOMA CITY, OK.

Between 2021 and 2025, Dr. ARULKUMAR had an overall industry promotional and research financial footprint of $158,278 as recorded in the federal CMS Open Payments database.

$158,278 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ARULKUMAR's primary funding source is NALU MEDICAL, which accounts for $155,035 (representing 98% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NALU MEDICAL

Rank 1

$155,035

98%

RELIEVANT MEDSYSTEMS

Rank 2

$1,055

0.7%

BOSTON SCIENTIFIC CORPORATION

Rank 3

$534

0.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.